Back to search

Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer

Data up to Jan 2025

Published2002
Citations479
References34
Clinical Trials (1)

Total Citations Per Year

Abstract

References (34)

Cluster analysis and display of genome-wide expression patterns

1998 • 16,410 citations

The fundamental role of epigenetic events in cancer

2002 • 5,532 citations

Genetic instabilities in human cancers

1998 • 4,165 citations

Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

1994 • 3,536 citations

Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors

1992 • 3,344 citations

The IARC TP53 database: New online mutation analysis and recommendations to users

2002 • 1,248 citations

Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast Cancer

2000 • 927 citations

Annual Report to the Nation on the status of cancer, 1973–1999, featuring implications of age and aging on U.S. cancer burden

2002 • 896 citations

A Mutator Phenotype in Cancer 1

2001 • 675 citations

Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients

1992 • 563 citations

Detection and Clinical Importance of Micrometastatic Disease

1999 • 505 citations

Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells

1999 • 449 citations

Lack of Effect of Adjuvant Chemotherapy on the Elimination of Single Dormant Tumor Cells in Bone Marrow of High-Risk Breast Cancer Patients

2000 • 387 citations

Prognostic Value of Immunohistochemically Identifiable Tumor Cells in Lymph Nodes of Patients with Completely Resected Esophageal Cancer

1997 • 370 citations

Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies.

1987 • 316 citations

Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases

1996 • 314 citations

An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control

1998 • 241 citations

Prognostic significance of bone marrow micrometastases in patients with gastric cancer.

1996 • 195 citations

Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer.

1994 • 183 citations

Genetic divergence in the clonal evolution of breast cancer.

1996 • 164 citations

Precise microdissection of human prostate cancers reveals genotypic heterogeneity.

1998 • 159 citations

Heterogeneity in intratumor distribution of p53 mutations in human prostate cancer.

1995 • 120 citations

Cytogenetic analysis of pancreatic carcinomas: Intratumor heterogeneity and nonrandom pattern of chromosome aberrations

1998 • 116 citations

DISSEMINATED CYTOKERATIN POSITIVE TUMOR CELLS IN THE BONE MARROW OF PATIENTS WITH PROSTATE CANCER: DETECTION AND PROGNOSTIC VALUE

2001 • 100 citations

Adjuvant therapy of colon cancer

2001 • 82 citations

Primary human prostate cancer cells harboring p53 mutations are clonally expanded in metastases.

1997 • 78 citations

Cytogenetic comparison of primary tumors and lymph node metastases in breast cancer patients

1998 • 55 citations

Epithelial cells in bone marrow of oesophageal cancer patients: a significant prognostic factor in multivariate analysis

2000 • 54 citations

Cytogenetic polyclonality in tumors of the breast

1997 • 54 citations

Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast Cancer

2000 • 47 citations

Adjuvant and neoadjuvant therapy in prostate cancer

2001 • 36 citations

Adjuvant and neoadjuvant treatment of breast cancer

2001 • 29 citations

The biology and analysis of single disseminated tumour cells

2000 • 28 citations

Introduction: The evolution of early systemic therapy

2001 • 1 citations

Cited By (0)

Loading...
Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer (2002) – The Lancet | Metascience Observatory Explorer